REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hekapharma S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hekapharma S.A. Profile Updated: February 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Hekapharma S.A. is a company based in Ecuador, with its head office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on March 09, 2020. 2 (2024) employees currently work for Hekapharma S.A.. The company’s latest financial report indicates a net sales revenue increase of 53.51% in 2024. Its total assets grew by 51.72% over the same period. The net profit margin of Hekapharma S.A. decreased by 7.52% in 2024.

Headquarters
San Mateo Lt 11
Quito; Pichincha;

Contact Details: Purchase the Hekapharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Hekapharma S.A. report to view the information.
Registered Capital:
Purchase the Hekapharma S.A. report to view the information.
Financial Auditors:
Purchase the Hekapharma S.A. report to view the information.
Incorporation Date:
March 09, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Hekapharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
53.51%▲
Total operating revenue
53.51%▲
Operating profit (EBIT)
61.95%▲
EBITDA
71.28%▲
Net Profit (Loss) for the Period
-33573.9%▼
Total assets
51.72%▲
Total equity
-41.51%▼
Operating Profit Margin (ROS)
22.39%▲
Net Profit Margin
-7.52%▼
Return on Equity (ROE)
8.16%▲
Quick Ratio
3.77%▲
Cash Ratio
0.78%▲

Similar companies

Quifatex S.A.
 
Laboratorios Siegfried S.A.
Roche Ecuador S.A.
 
Bayer S.A.
Nefrocontrol S.A.
 
Novartis Ecuador S.A.
Derostic Corp. CIA Ltda
 
James Brown Pharma C.A.
Laboratorios Luque CIA Ltda
 
Ceuticals S.A.S.
Vet And Livestok Logistics S.A.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo